PK/PD Clinical Trial of YYD601 in Healthy Adult Male

A Dose Blocked-randomized, Open-label, Parallel Design Clinical Trial to Assess the Pharmacokinetic/Pharmacodynamic Properties and Safety of YYD601 After Oral Administration in Healthy Adult Male Volunteers(Phase 1)

A dose block-randomized, open-label, parallel clinical trial

This study to evaluate comparatively a characteristics and safety of the PK/PD of single/repeated oral administration YYD601 and Nexium tab and the effects of food influence the PK/PD of YYD601 in healthy adult male.

Inclusion criteria:

• Healthy adult male above 19 years old when getting a screening test.
• Subjects who have over 50kg weight, included in the IBW± 20% range. [IBW(kg)={height(cm)-100}x0.9
• Subjects who haven't any congenital or chronic disease, and any other disease following the medical examination.
• Subjects who are confirmed as a participant by the serum test, hematologital test, blood chemistry tests, urine tests, and clinical laboratory test, 12-lead EKG etc following the characteristics aboht the IP within the 3 weeks before investogator products are administrated.
• Subjects who voluntarily decide to participated in this trial after comletely understand about this clinical trial.

Exclusion criteria

• Subjects who are judged not suitable to participated in this trial.
• Other specific exlusion criteria is identified in the protocol.